<DOC>
	<DOCNO>NCT01291212</DOCNO>
	<brief_summary>The investigator previously demonstrate utility transdermal testosterone vitro fertilization ( IVF ) low responder patient . Now , investigator want evaluate efficacy luteinizing hormone ( LH ) activity add recombinant follicular stimulate hormone ( FSHr ) ovarian stimulation patient .</brief_summary>
	<brief_title>Efficacy Luteinizing Hormone ( LH ) Activity Low Responder Patients With Transdermal Testosterone</brief_title>
	<detailed_description>Studies macaque indicate androgen synergistic effect follicular stimulate hormone ( FSH ) folliculogenesis . Our previous clinical study demonstrate usefulness pretreatment transdermal testosterone low-responder IVF patient . There controversy usefulness recombinant luteinizing hormone ( LHr ) add FSHr ovarian stimulation low responder patient . Thus , present study design compare ovarian stimulation FSHr alone versus LHr add FSHr transdermal testosterone pretreatment use .</detailed_description>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Low responder patient : patient previously cancel cycle recovery 3 less oocyte FSH &gt; 12 Previous ovarian surgery</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>41 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>In Vitro Fertilization</keyword>
	<keyword>Testosterone</keyword>
	<keyword>Ovarian Stimulation</keyword>
	<keyword>Luteinizing Hormone</keyword>
</DOC>